covid novavax - Search News

Order byBest matchMost fresh

Novavax scores narrower Covid vaccine approval

Healthy Returns: Novavax scores narrower Covid vaccine approval after delay

Novavax can finally breathe a sigh of relief – at least a small one. The Food and Drug Administration approved the company's Covid-19 vaccine after more than a month of delay b

MPR · 4h

FDA’s New COVID-19 Vaccine Approval Policy May Limit Future Access

· 2d · on MSN

FDA approves Novavax COVID vaccine with new conditions

· 18h

FDA tightens requirements for COVID vaccine, adding trials for healthy adults

Reuters, the news and media division of Thomson Reuters, is the world’s largest multimedia news provider, reaching billions of people worldwide every day.

· 19h

F.D.A. Poised to Restrict Access to Covid Vaccines

· 1d

Annual COVID-19 Shots For Healthy Younger Adults, Children Will No Longer Be Routinely Approved

· 4h

FDA plans to limit COVID vaccine to only high-risk people. Who would still be eligible?

Public trust in vaccination has declined, potentially impacting other vital immunization programs.

· 22h

New FDA rule could delay Covid vaccine rollout for healthy adults and kids

· 1d

FDA sets new COVID booster guidelines for healthy adults under 65

6hon MSN

Who can get updated COVID vaccines this fall? FDA will OK for high-risk groups, calls for new clinical trials

The Food and Drug Administration says it has decided to continue approving COVID-19 vaccine updates for seniors and others at higher risk of severe disease, but will require vaccine makers to conduct major new clinical trials before approving them for wider use.

2hon MSN

FDA may limit future COVID-19 boosters to seniors, those at higher risk for complications

US Food and Drug Administration officials are changing the agency's standards for updated COVID-19 booster shots with focus on seniors, high-risk persons.

FDA’s new approach raises questions about fall COVID vaccine availability

Health experts say there are legitimate questions about how much everyone still benefits from yearly COVID vaccination or whether they should be recommended only for people at increased risk.

19hon MSN

FDA sets new COVID booster guidelines for healthy adults under 65

The FDA plans to require new clinical trials for approval of annual COVID-19 boosters for healthy Americans under 65.

BioPharma Dive2d

Novavax’s COVID vaccine gets FDA approval, but with limits

While the clearance is only for use in certain groups, Novavax’s long-awaited OK is still seen by analysts as a “win” for the company.

Trump Administration Releases New COVID-19 Vaccine Plan: What to Know

In a major policy shift, federal health officials anticipate the shots will be made available to adults 65 and older as well as children and younger adults who have one or more risk factors that make them more vulnerable to severe COVID-19.